Publications And Positive Data From Multiple Trials: Six Mon

Tiziana Life Sciences (NASDAQ: TLSA) is a biotechnology company establishing itself in a cutting-edge position in the market with its b

Related Keywords

Provention Bio , Tea Program , Proceedings Of The National Academy Sciences , Drug Administration , Tiziana Life , Secondary Progressive Multiple Sclerosis , Applications For Foralumab , National Academy , Investigational New Drug , Hans Reniers ,